Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.
about
Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosisInterventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosisEradication therapy for Burkholderia cepacia complex in people with cystic fibrosisInterventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosisInhaled antibiotics for pulmonary exacerbations in cystic fibrosisInhaled antibiotics for long-term therapy in cystic fibrosisNebulised anti-pseudomonal antibiotics for cystic fibrosisInhaled therapy in cystic fibrosis: agents, devices and regimensColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyInhaled Antibiotic Therapy in Chronic Respiratory Diseases.Aerosolized antimicrobial therapy in acutely ill patients.Nebulized antibiotic therapy: the evidence.Eradication of early Pseudomonas infection in cystic fibrosis.Inhaled colistin for lower respiratory tract infections.Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature.Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.Bronchodilators in cystic fibrosis: a critical analysis.Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects.Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges.Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.Bronchoconstriction following nebulised colistin in cystic fibrosis.Pulmonary deposition of inhaled tobramycin prior to and after respiratory therapy and use of inhaled albuterol in cystic fibrosis patients colonized with Pseudomonas aeruginosa.Prevention of chronic Pseudomonas aeruginosa infection in people with cystic fibrosis.
P2860
Q24186014-2B4A2786-7CC4-4362-A1B1-C606C36B8043Q24187987-5019D783-13B3-4A98-957A-8C73A1E1A73AQ24193082-ED1EE311-DA10-4247-9541-E36B6B5B67EDQ24200822-07694A9F-3CFD-43E3-A88D-21399074ADA7Q24202283-3AE60628-5943-41A1-97C6-9865489C3E60Q24235635-D5CD2A52-45C6-4F53-AE7C-6C3DEC805844Q24247996-744DB39C-745F-4A15-BB47-08CEF61AB9B3Q26797450-3CE7F6E7-D8FF-43C8-8806-7B3D7C77611BQ27014993-60492902-53EB-46ED-B4B6-4EAB8035DE34Q33755342-3EA1EE68-47D0-431E-892C-EB068DD35317Q33839762-FBD1F6DF-B62C-42B5-9C93-FF122953A9B3Q36310044-D3A6A158-FC59-41BB-BE49-0A7760B781F6Q37468065-6CE4206A-0F56-4AFC-B687-E12AD42CFBDBQ37983920-60C45EAF-5762-49C5-88A1-195F2F6D380AQ38123731-C77700FC-5349-47A9-859E-63546A7CFF47Q38186636-4804CC0C-F07A-490B-9EE0-FCCBBE5E8438Q38975700-4D97672D-65E0-424B-A2F2-99962AADC61AQ38996423-04BB5197-71DE-402B-9925-101B260E7163Q40121090-35ED85C1-EDA5-4D25-A065-755D4ACFD0F1Q40422166-B1A4152F-F266-4F3B-9846-A4A3B849F4DCQ41847225-F786E303-E877-4DB1-8397-7C2AA49FD000Q41906174-DEC4E0EB-1A18-4CE0-A111-ADB17B751A63Q46121186-4494BB80-16DB-404F-ADC8-CC6AC68A4C26Q52847673-89905CC5-75D9-42BE-B457-A791FF2A4B6E
P2860
Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@ast
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@en
type
label
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@ast
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@en
prefLabel
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@ast
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Effect of tonicity of nebulise ...... n adults with cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1136/THX.52.7.656
P407
P577
1997-07-01T00:00:00Z